CA2635378A1 - Compositions pharmaceutiques et methodes pour eradication bacterienne amelioree - Google Patents

Compositions pharmaceutiques et methodes pour eradication bacterienne amelioree Download PDF

Info

Publication number
CA2635378A1
CA2635378A1 CA002635378A CA2635378A CA2635378A1 CA 2635378 A1 CA2635378 A1 CA 2635378A1 CA 002635378 A CA002635378 A CA 002635378A CA 2635378 A CA2635378 A CA 2635378A CA 2635378 A1 CA2635378 A1 CA 2635378A1
Authority
CA
Canada
Prior art keywords
antibiotic
penicillin
dosage form
composition
mic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002635378A
Other languages
English (en)
Other versions
CA2635378C (fr
Inventor
Henry H. Flanner
Robert J. Guttendorf
Susan P. Clausen
Donald J. Treacy
Beth A. Burnside
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2635378A1 publication Critical patent/CA2635378A1/fr
Application granted granted Critical
Publication of CA2635378C publication Critical patent/CA2635378C/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA2635378A 2005-12-08 2006-12-08 Compositions pharmaceutiques et methodes pour eradication bacterienne amelioree Expired - Fee Related CA2635378C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US74866005P 2005-12-08 2005-12-08
US60/748,660 2005-12-08
US79810906P 2006-05-05 2006-05-05
US60/798,109 2006-05-05
PCT/US2006/047040 WO2007067770A2 (fr) 2005-12-08 2006-12-08 Compositions pharmaceutiques et méthodes pour éradication bactérienne améliorée

Publications (2)

Publication Number Publication Date
CA2635378A1 true CA2635378A1 (fr) 2007-06-14
CA2635378C CA2635378C (fr) 2015-06-16

Family

ID=38123546

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2635378A Expired - Fee Related CA2635378C (fr) 2005-12-08 2006-12-08 Compositions pharmaceutiques et methodes pour eradication bacterienne amelioree

Country Status (4)

Country Link
EP (1) EP1968586A4 (fr)
AU (1) AU2006321782B2 (fr)
CA (1) CA2635378C (fr)
WO (1) WO2007067770A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7966694A (en) * 1993-07-21 1996-05-02 University Of Kentucky Research Foundation, The A multicompartment hard capsule with control release properties
US6544555B2 (en) * 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6610328B2 (en) * 2000-02-24 2003-08-26 Advancis Pharmaceutical Corp. Amoxicillin-clarithromycin antibiotic composition
US6730320B2 (en) * 2000-02-24 2004-05-04 Advancis Pharmaceutical Corp. Tetracycline antibiotic product, use and formulation thereof
DE602004016963D1 (en) * 2003-02-21 2008-11-20 Lek Pharmaceuticals Therapeutisches system mit amoxicillin und clavulansäure
AU2003290394A1 (en) * 2003-09-30 2005-04-14 Lupin Ltd. Extended release formulation of beta-lactam antibiotics

Also Published As

Publication number Publication date
AU2006321782A1 (en) 2007-06-14
WO2007067770A2 (fr) 2007-06-14
AU2006321782B2 (en) 2012-11-29
WO2007067770A3 (fr) 2008-02-21
EP1968586A4 (fr) 2011-12-21
EP1968586A2 (fr) 2008-09-17
CA2635378C (fr) 2015-06-16

Similar Documents

Publication Publication Date Title
US8357394B2 (en) Compositions and methods for improved efficacy of penicillin-type antibiotics
US8299052B2 (en) Pharmaceutical compositions and methods for improved bacterial eradication
US9144548B2 (en) Antibiotic product, use and formulation thereof
US8313775B2 (en) Antibiotic product, use and formulation thereof
US8313776B2 (en) Antibiotic product, use and formulation thereof
AU2006321782B2 (en) Pharmaceutical compositions and methods for improved bacterial eradication
US8425936B2 (en) Antibiotic product, use and formulation thereof
US8246996B2 (en) Antibiotic product, use and formulation thereof
US8460710B2 (en) Antibiotic product, use and formulation thereof

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20201208